The assay is designed to detect ribosomal RNA from four clinically relevant Babesia species and runs on the company's Procleix Panther system.
The New York Times warns in an editorial that 23andMe health risk tests may not provide useful information.
Direct-to-consumer genetic testing firm 23andMe has a newly cleared colorectal cancer risk test.
The clearance enables 23andMe to report on the two most common variations in the MUTYH gene influencing MAP, which increases risk of CRC development.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
Data from the GUIDED study will be central to commercial payor discussions, a Medicare LCD reconsideration request, and eventually expansion into the primary care market.
Sequencing has helped identify where an E. coli outbreak may have originated, the Atlanta Journal-Constitution reports.
The partial federal government shutdown in the US affects a number of science agencies, ScienceInsider reports.
The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.